Ignite Creation Date:
2024-05-06 @ 4:32 PM
Last Modification Date:
2024-10-26 @ 2:11 PM
Study NCT ID:
NCT05016349
Status:
UNKNOWN
Last Update Posted:
2021-08-23
First Post:
2021-08-17
Brief Title:
Investigating the Potential Role of a Novel Quadrate Combination Therapy MifepristoneAntiprogestrone Tamoxifen Retinoic Acid and Cannabidiol Selective Cyp 26 Inhibitor for Treating Early Breast Cancer
Sponsor:
Mahmoud Ramadan mohamed Elkazzaz
Organization:
Kafrelsheikh University
Organization Data
Organization:
Kafrelsheikh University
Class:
OTHER
Study ID:
New theoryTamoxifenretinoic
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mahmoud Ramadan mohamed Elkazzaz
Lead Sponsor Class:
OTHER
Responsible Party:
Mahmoud Ramadan mohamed Elkazzaz
Responsible Party Title:
Clinical Researcher
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Kafrelsheikh University
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Ministry of Health Saudi Arabia | OTHER_GOV |